Obese adults facing Medicaid expansion gap

April 30, 2020

Despite overall increases in insurance coverage for low-income individuals in Medicaid expansion states, some gaps remain for individuals who are obese.

That's according to a recent study by a team of researchers at the University of Georgia.

The findings, published in the journal Obesity, show a slower uptake of Medicaid enrollment among low-income obese individuals compared to low-income, non-obese individuals - 5.6% increase in coverage versus 7.4%, respectively.

Though obesity is an issue that impacts individuals of all income levels, evidence points to a higher risk among low-income groups.

The prevention and treatment of obesity requires regular access to health care, said lead author Janani Thapa, an assistant professor of health policy and management at UGA's College of Public Health, and that often requires having health insurance.

"We want more people with obesity to have access to insurance so that they can have their annual checkup, and know their risks of other conditions associated with higher weight on the prevention side," said Thapa, "but also, on the treatment side, if these individuals do not have insurance, they cannot access any health care intervention because of cost."

Since the rollout of the Affordable Care Act in 2010, changes in the uninsured rate have been tracked and reported by government agencies, health advocacy groups and many academic researchers.

Yet, little work has been done to understand whether equal improvement in access to insurance has been achieved among key subgroups, such as low-income groups who were obese and who were not obese, through Medicaid expansion.

Thapa said the uneven rollout of Medicaid expansion among states provided a natural experiment for her team. States that expanded Medicaid served as a treatment group. States that did not expand were the control.

The results of their experiment confirmed that Medicaid expansion provided more coverage to low-income Americans, both obese and non-obese. The observed gaps, said the researchers, should not diminish the positive impact of Medicaid expansion.

But their findings should prompt more action to help more individuals in need, said co-author Donglan Zhang, also an assistant professor of health policy and management in UGA's College of Public Health.

"Our findings reconfirmed the critical importance of Medicaid expansion and that states should do more to help obese individuals get insurance coverage, with community outreach programs and public education to help more qualified individuals sign up for Medicaid coverage, and with legislative efforts or an expansion of existing safety net programs for those non-expanded states," she said.
-end-
Co-authors are Donglan "Stacy" Zhang, Kara E. MacLeod and Kiran Thapa.

University of Georgia

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.